Dialogical Family Guidance for Neurodevelopmental Disorders

NCT ID: NCT04892992

Last Updated: 2021-05-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-06

Study Completion Date

2018-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Previous studies have highlighted the need to offer targeted effective interventions to strengthen the wellbeing of all family members in families with children with neurodevelopmental disorders (NDD). Interventions for this target group requires development and research. A new family intervention, Dialogical Family Guidance (DFG) was tested in this study. All families received DFG intervention ( 6 meetings ).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Previous studies have highlighted the need to offer targeted effective interventions to strengthen the wellbeing of all family members in families with children with neurodevelopmental disorders (NDD). Interventions for this target group requires development and research. A new family intervention, Dialogical Family Guidance (DFG) was tested in this study.

Fifty families of children with NDD were randomized into two intervention groups. Intervention group I were delivered DFG immediately, and Intervention group II were delivered DFG after three months. Family functionality, health and support (FAFHES), SDQ and the 5-15-questionnaire and DFG parent questionnaires were used to collect data at baseline, after three and six months. Fifty families were invited to the study. Thirty-four families completed the study. A comparison were made between Intervention group I and II.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Family Dynamics

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Intervention group I were delivered DFG immediately and Intervention group II were delivered DFG after three months.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants
Intervention group I were delivered DFG immediately, and Intervention group II were delivered DFG after three months.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group I

6 sessions of intervention DFG starting at once (baseline). After DFG treatment as usual at Helsinki University hospital. The change between before the intervention (baseline) and after the intervention (3 months later) is being assessed.

Group Type EXPERIMENTAL

DFG

Intervention Type BEHAVIORAL

Intervention group II

6 sessions of intervention DFG starting 3 months after baseline (3 months on waiting list). Between baseline and 3 months waiting list families were getting treatment as usual at Helsinki University hospital. The change between baseline - after 3 months waiting list (3 months from baseline)/ before the intervention - and after intervention (6 months from baseline) is being assessed. Also the difference between Intervention group I and II is assessed.

Group Type EXPERIMENTAL

DFG

Intervention Type BEHAVIORAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

DFG

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* clinical neurodevelopmental disorder diagnosis (eg ADHD, ASD, tics, language disorders)
* the child is aged between 4-16 years
* parent have adequate Finnish language skills
* parents are biological parents or step-parents of the child

Exclusion Criteria

* the child is under 4 or over 16 years old
* parents do not have adequate Finnish language skills
Minimum Eligible Age

5 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Diana Cavonius-Rintahaka

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Diana Cavonius-Rintahaka

PhD candidate

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Diana Cavonius-Rintahaka, MhSc

Role: PRINCIPAL_INVESTIGATOR

Tampere University

References

Explore related publications, articles, or registry entries linked to this study.

Cavonius-Rintahaka D, Roos M, Aho AL. The effectiveness of a dialogical family guidance intervention regarding child treatment response in families with a child with neurodevelopmental disorders. BMC Psychol. 2024 Apr 5;12(1):189. doi: 10.1186/s40359-024-01706-9.

Reference Type DERIVED
PMID: 38580992 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

106/13/03/03/2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Dance for Children With Autism
NCT04762290 COMPLETED NA
Cognitive Control and Metacognition Training
NCT06885684 NOT_YET_RECRUITING NA